Induced Foxp3 + regulatory T cells: A potential new weapon to treat autoimmune and inflammatory diseases?

Journal of Molecular Cell Biology

Volumn 4, Issue 1, 2012, Pages 22-28

  Lan, Qin ^a,b   Fan, Huimin ^a   Quesniaux, Valerie ^c   Ryffel, Bernhard ^c   Liu, Zhongmin ^a   Zheng, Song Guo ^b,c  

^a TONGJI UNIVERSITY   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Molecular Immunology   (France)

Author keywords

atRA; autoimmune and inflammatory diseases; Foxp3; immunoregulation; regulatory T cells; TGF ; Th17 cells

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

AUTOIMMUNE DISEASE; CELL MATURATION; CELL THERAPY; HUMAN; INFLAMMATORY DISEASE; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW;

ADOPTIVE TRANSFER; ANIMALS; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CELL TRANSPLANTATION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INFLAMMATION; INTERLEUKINS; MICE; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION IMMUNOLOGY;

ATRA;

EID: 84863011078     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mjr039     Document Type: Review

References (73)

1. Allan, S.E., Crome, S.Q., Crellin, N.K., et al. (2007). Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19, 345-354. (Pubitemid 46523383)
2. + regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J. Exp. Med. 205, 1975-1981.
3. + T cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis. J. Immunol. 175, 944-950. (Pubitemid 41094978)
4. + regulatory T cells. J. Mol. Cell Biol. 2, 30-36.
5. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886. (Pubitemid 38032120)
6. + T cells in vivo. J. Immunol. 186, 6329-6337.
7. + regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J. Immunol. 179, 4685-4693.
8. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172, 5149-5153. (Pubitemid 38542009)
9. + regulatory T cells suppress Th1-mediated experimental colitis. Gut 55, 671-680.
10. Floess, S., Freyer, J., Siewert, C., et al. (2007). Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5, e38.
11. + regulatory T cells. Nat. Immunol. 4, 330-336. (Pubitemid 36432314)
12. Gershon, R.K., and Kondo, K. (1970). Cell interactions in the induction of tolerance: The role of thymic lymphocytes. Immunology 18, 723-737.
13. Godebu, E., Summers-Torres, D., Lin, M.M., et al. (2008). Polyclonal adaptive regulatory CD4 cells that can reverse type I diabetes become oligoclonal long-term protective memory cells. J. Immunol. 181, 1798-1805.
14. +CD25 high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 35, 3343-3352. (Pubitemid 41672538)
15. Hippen, K.L., Merkel, S.C., Schirm, D.K., et al. (2011). Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am. J. Transplant. 11, 1148-1157.
16. + regulatory T cells upon repetitive in vitro stimulation. Eur. J. Immunol. 39, 1088-1097.
17. Horwitz, D.A., Zheng, S.G., Gray, J.D., et al. (2004). Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Semin. Immunol. 16, 135-143. (Pubitemid 38234764)
18. + regulatory T cells are not mirror images of each other. Trends Immunol. 29, 429-435.
19. Housley, W.J., Adams, C.O., Nichols, F.C., et al. (2011). Natural but not inducible regulatory T cells require TNF-alpha signaling for in vivo function. J. Immunol. 186, 6779-6787.
20. Huter, E.N., Stummvoll, G.H., DiPaolo, R.J., et al. (2008). Cutting edge: Antigenspecific TGF beta-induced regulatory T cells suppress Th17-mediated autoimmune disease. J. Immunol. 181, 8209-8213.
21. + Treg revert in vivo and do not protect from experimental GVHD. Eur. J. Immunol. 39, 3091-3096.
22. + T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis. J. Neuroimmunol. 180, 178-184. (Pubitemid 44767710)
23. + regulatory T cells in vivo requires B7 costimulation, but not the thymus. J. Exp. Med. 201, 127-137. (Pubitemid 40130090)
24. + Treg. Eur. J. Immunol. 40, 142-152.
25. Lu, L., Wang, J., Zhang, F., et al. (2010b). Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells. J. Immunol. 184, 4295-4306.
26. Lu, L., Zhou, X., Wang, J., et al. (2010c). Characterization of protective human CD4CD25FOXP3 regulatory T cells generated with IL-2, TGF-beta and retinoic acid. PLoS One 5, e15150.
27. Lu, L., Ma, J., Li, Z., et al. (2011). All-trans retinoic acid promotes TGF-beta-induced Tregs via histone modification but not dna demethylation on Foxp3 gene locus. PLoS One 6, e24590.
28. Miyara, M., Amoura, Z., Parizot, C., et al. (2005). Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol. 175, 8392-8400. (Pubitemid 41798406)
29. + T cells expressing the FoxP3 transcription factor. Immunity 30, 899-911.
30. + cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum. 48, 1452-1460. (Pubitemid 36554546)
31. + T regulatory cells in humans. Hum. Immunol. 66, 13-20. (Pubitemid 40037706)
32. Nguyen, T.L., Sullivan, N.L., Ebel, M., et al. (2011). Antigen-specific TGF-beta-induced regulatory T cells secrete chemokines, regulate T cell trafficking, and suppress ongoing autoimmunity. J. Immunol. 187, 1745-1753.
33. O'Connor, R.A., Leech, M.D., Suffner, J., et al. (2010). Myelin-reactive, TGF-beta-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelinreactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo. J. Immunol. 185, 7235-7243.
34. + T cell-mediated suppression by dendritic cells. Science 299, 1033-1036. (Pubitemid 36222922)
35. Penaranda, C., and Bluestone, J.A. (2009). Is antigen specificity of autoreactive T cells the key to islet entry? Immunity 31, 534-536.
36. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J. Exp. Med. 196, 237-246.
37. Pot, C., Apetoh, L., and Kuchroo, V.K. (2011). Type 1 regulatory T cells (Tr1) in autoimmunity. Semin. Immunol. 23, 202-208.
38. Qian, X., Wang, K., Wang, X., et al. (2011). Generation of human regulatory T cells de novo with suppressive function prevent xenogeneic graft versus host disease. Int. Immunopharmacol. 11, 630-637.
39. + regulatory T cells abrogates their function in vivo. J. Immunol. 177, 4376-4383. (Pubitemid 44469766)
40. Sakaguchi, S., Sakaguchi, N., Asano, M., et al. (1995). Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alphachains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164.
41. Salliot, C., Finckh, A., Katchamart, W., et al. (2011). Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: A meta-analysis. Ann. Rheum. Dis. 70, 266-271.
42. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431-440.
43. Sauer, S., Bruno, L., Hertweck, A., et al. (2008). T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl Acad. Sci. USA 105, 7797-7802. (Pubitemid 351872718)
44. Scalapino, K.J., Tang, Q., Bluestone, J.A., et al. (2006). Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J. Immunol. 177, 1451-1459. (Pubitemid 44092478)
45. Seddiki, N., Santner-Nanan, B., Martinson, J., et al. (2006). Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203, 1693-1700. (Pubitemid 44036275)
46. + regulatory T lymphocytes through the induction of anergy and infectious tolerance. J. Immunol. 180, 2830-2838.
47. Serre, K., Benezech, C., Desanti, G., et al. (2011). Helios is associated with CD4 T cells differentiating to T helper 2 and follicular helper T cells in vivo independently of Foxp3 expression. PLoS One 6, e20731.
48. + T cells. J. Immunol. 179, 1427-1430.
49. + regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease. Br. J. Dermatol. 158, 1197-1209. (Pubitemid 351692882)
50. Takeuchi, M., Inoue, T., Otani, T., et al. (2010). Cell-in-cell structures formed between human cancer cell lines and the cytotoxic regulatory T-cell line HOZOT. J. Mol. Cell Biol. 2, 139-151.
51. + regulatory T cell: A jack of all trades, master of regulation. Nat. Immunol. 9, 239-244. (Pubitemid 351267321)
52. + T regulatory cells. J. Immunol. 184, 3433-3441.
53. +FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110, 2983-2990. (Pubitemid 350006952)
54. + regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes 57, 113-123.
55. + T cells in gut Peyer's patches. Science 323, 1488-1492.
56. +CD25 hi T-regulatory cells. Blood 108, 253-261. (Pubitemid 43990636)
57. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199, 971-979. (Pubitemid 38481088)
58. Wan, Y.Y., and Flavell, R.A. (2007). Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445, 766-770. (Pubitemid 46279706)
59. Weber, S.E., Harbertson, J., Godebu, E., et al. (2006). Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J. Immunol. 176, 4730-4739.
60. Wildin, R.S., Ramsdell, F., Peake, J., et al. (2001). X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27, 18-20. (Pubitemid 32044512)
61. - T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J. Immunol. 178, 6725-6729. (Pubitemid 46847395)
62. + regulatory T cells from human peripheral blood. J. Immunol. 166, 7282-7289. (Pubitemid 32525603)
63. + regulatory T cells in untreated active systemic lupus erythematosus secondary to interferonalpha- producing antigen-presenting cells. Arthritis Rheum. 58, 801-812. (Pubitemid 351364878)
64. Yu, S.L., Wong, C.K., Wong, P.T., et al. (2011). Down-regulated NOD2 by immunosuppressants in peripheral blood cells in patients with SLE reduces the muramyl dipeptide-induced IL-10 production. PLoS One 6, e23855.
65. - precursors. J. Immunol. 169, 4183-4189. (Pubitemid 35178188)
66. - cells to develop suppressive activity: The role of IL-2, TGF-beta, and IL-10. J. Immunol. 172, 5213-5221. (Pubitemid 38542018)
67. + regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J. Immunol. 172, 1531-1539. (Pubitemid 38116797)
68. + regulatory cells. J. Immunol. 176, 3321-3329. (Pubitemid 43363978)
69. + regulatory T cells and for expansion of these cells. J. Immunol. 178, 2018-2027. (Pubitemid 46233398)
70. + regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J. Immunol. 180, 7112-7116.
71. + regulatory T cells using FACS sorting on scatter plot. J. Mol. Cell Biol. 2, 164-169.
72. Zhou, X., Kong, N., Wang, J., et al. (2010b). Cutting edge: All-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu. J. Immunol. 185, 2675-2679.
73. + regulatory T cells in autoimmune diseases. Autoimmunity 44, 43-50.